ADGRL3 and Alzheimer disease: Therefore, the end products of the reaction of AD, DLB, and PSP BDTOs preincubated with 5 μm CL3 were resolved in a SDS-PAGE, followed by WB analysis using Tau 5 antibody, which showed a different pattern of immunoreactivity for each type of BDTO (Fig. 3, A, C, and E).